All 1 tracked stories fall under one category: clinical-trial. Genomics Aotearoa is most often covered alongside Māori and Pacific populations, which appears in 1 of these 1 story. The tracked stories average 2 original sources each. Genomics Aotearoa appears in 1 tracked Biotech story from March 18, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Genomics Aotearoa
All 1 tracked stories fall under one category: clinical-trial. Genomics Aotearoa is most often covered alongside Māori and Pacific populations, which appears in 1 of these 1 story. The tracked stories average 2 original sources each. Genomics Aotearoa appears in 1 tracked Biotech story from March 18, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 18 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Genomics Aotearoa. Shared-story counts are live from our verified record — not editorial picks.
New Zealand has initiated a major genomic medicine trial designed to provide locally-based genetic sequencing for patients battling cancer and rare diseases. By repatriating diagnostic capabilities, the program aims to accelerate treatment timelines and improve health equity across the country's diverse populations.
Genomics Aotearoa is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.